204 related articles for article (PubMed ID: 34233293)
1. Glycolysis- and immune-related novel prognostic biomarkers of Ewing's sarcoma: glucuronic acid epimerase and triosephosphate isomerase 1.
Jiang J; Zhan X; Xu G; Liang T; Yu C; Liao S; Chen L; Huang S; Sun X; Yi M; Zhang Z; Yao Y; Liu C
Aging (Albany NY); 2021 Jul; 13(13):17516-17535. PubMed ID: 34233293
[TBL] [Abstract][Full Text] [Related]
2. Novel prognostic biomarkers, METTL14 and YTHDF2, associated with RNA methylation in Ewing's sarcoma.
Jiang J; Fan Q; Qu H; Liu C; Liang T; Chen L; Huang S; Sun X; Chen J; Chen T; Li H; Yao Y; Zhan X
Sci Rep; 2022 Apr; 12(1):7041. PubMed ID: 35487915
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cell surface antigen HBA71 (p30/32MIC2), neuron-specific enolase, and vimentin in the immunohistochemical analysis of Ewing's sarcoma of bone.
Fellinger EJ; Garin-Chesa P; Glasser DB; Huvos AG; Rettig WJ
Am J Surg Pathol; 1992 Aug; 16(8):746-55. PubMed ID: 1497115
[TBL] [Abstract][Full Text] [Related]
4. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT).
Machado I; López-Guerrero JA; Scotlandi K; Picci P; Llombart-Bosch A
Virchows Arch; 2018 May; 472(5):815-824. PubMed ID: 29445891
[TBL] [Abstract][Full Text] [Related]
6. Construction of a prognostic signature in Ewing's sarcoma: Based on metabolism-related genes.
Fu Z; Yu B; Liu M; Wu B; Hou Y; Wang H; Jiang Y; Zhu D
Transl Oncol; 2021 Dec; 14(12):101225. PubMed ID: 34555728
[TBL] [Abstract][Full Text] [Related]
7. Detection of early prognostic biomarkers for metastasis of Ewing's sarcoma in pediatric patients.
Ezzeldin S; Osama A; Anwar AM; Mahgoub S; Ahmed EA; Farid N; Zamzam M; El Ghoneimy A; Magdeldin S
Life Sci; 2023 Dec; 334():122237. PubMed ID: 37926299
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
9. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
[TBL] [Abstract][Full Text] [Related]
10. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning.
Ren EH; Deng YJ; Yuan WH; Wu ZL; Zhang GZ; Xie QQ
J Cancer Res Clin Oncol; 2021 Jan; 147(1):153-165. PubMed ID: 32968877
[TBL] [Abstract][Full Text] [Related]
11. Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing.
Atzpodien J; Gulati SC; Shimazaki C; Bührer C; Oz S; Kwon JH; Kolitz JE; Clarkson BD
Oncology; 1988; 45(6):437-43. PubMed ID: 3263598
[TBL] [Abstract][Full Text] [Related]
12. [Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].
Delaplace M; Mélard P; Perrinaud A; Goré C; Vergier B; Machet L
Ann Dermatol Venereol; 2011 May; 138(5):395-8. PubMed ID: 21570564
[TBL] [Abstract][Full Text] [Related]
13. Overcoming cetuximab resistance in Ewing's sarcoma by inhibiting lactate dehydrogenase-A.
Fu J; Jiang H; Wu C; Jiang Y; Xiao L; Tian Y
Mol Med Rep; 2016 Jul; 14(1):995-1001. PubMed ID: 27222229
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma.
Fuchs B; Inwards CY; Janknecht R
Clin Cancer Res; 2004 Feb; 10(4):1344-53. PubMed ID: 14977835
[TBL] [Abstract][Full Text] [Related]
15. Current Status of Proteomics in Ewing's Sarcoma.
Kondo T
Proteomics Clin Appl; 2019 May; 13(3):e1700130. PubMed ID: 29992772
[TBL] [Abstract][Full Text] [Related]
16. Increased c-myc oncogene expression in Ewing's sarcoma: correlation with Ki67 proliferation index.
Sollazzo MR; Benassi MS; Magagnoli G; Gamberi G; Molendini L; Ragazzini P; Merli M; Ferrari C; Balladelli A; Picci P
Tumori; 1999; 85(3):167-73. PubMed ID: 10426126
[TBL] [Abstract][Full Text] [Related]
17. Conditional survival is greater than overall survival at diagnosis in patients with osteosarcoma and Ewing's sarcoma.
Miller BJ; Lynch CF; Buckwalter JA
Clin Orthop Relat Res; 2013 Nov; 471(11):3398-404. PubMed ID: 23821136
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics Analysis of ZBTB16 as a Prognostic Marker for Ewing's Sarcoma.
Ding K; Qiu W; Yu D; Ma H; Xie K; Luo F; Li S; Li Z; Wei J
Biomed Res Int; 2021; 2021():1989917. PubMed ID: 34660783
[TBL] [Abstract][Full Text] [Related]
19. Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma. A report from the Kiel Pediatric Tumor Registry.
Schmidt D; Herrmann C; Jürgens H; Harms D
Cancer; 1991 Nov; 68(10):2251-9. PubMed ID: 1655208
[TBL] [Abstract][Full Text] [Related]
20. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift.
Bridge JA; Fidler ME; Neff JR; Degenhardt J; Wang M; Walker C; Dorfman HD; Baker KS; Seemayer TA
Am J Surg Pathol; 1999 Feb; 23(2):159-65. PubMed ID: 9989842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
